Mineralys Therapeutics Balance Sheet (2022-2026) | MLYS

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter) 87.70M135.34M93.51M84.95M49.30M90.42M67.76M97.27M114.09M165.01M100.78M217.60M172.92M111.63M138.27M
Short-term Investments (Quarter) 22.41M132.39M159.96M167.46M187.26M248.15M243.26M166.33M84.10M178.00M223.10M376.03M483.71M533.30M523.14M
Cash & Current Investments (Quarter) 110.11M267.73M253.46M252.41M236.57M338.56M311.02M263.60M198.19M343.01M323.88M593.63M656.63M644.93M661.41M
Prepaid Assets (Quarter) 2.70M4.63M8.39M11.61M12.54M8.25M6.89M4.13M7.16M11.48M10.35M6.17M4.75M6.41M4.39M
Current Assets (Quarter) 112.81M275.27M269.49M265.38M249.10M346.82M318.00M267.73M205.35M354.51M335.27M599.80M661.39M652.47M665.80M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 0.05M0.04M0.07M0.05M0.04M0.02M0.01M0.04M0.03M0.03M
Long-Term Investments (Quarter) 31.12M21.68M12.13M2.48M
Other Non-Current Assets (Quarter) 1.63M0.04M0.05M0.05M0.05M0.38M0.45M0.45M0.50M0.40M0.43M0.14M0.38M0.36M2.02M
Non-Current Assets (Quarter) 1.63M31.16M21.73M12.18M2.53M0.43M0.49M0.52M0.55M0.43M0.46M0.15M0.42M0.39M2.05M
Assets (Quarter) 114.44M306.44M291.22M277.56M251.64M347.25M318.49M268.25M205.90M354.94M335.72M599.95M661.81M652.86M667.85M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 1.91M2.39M2.20M5.57M0.60M4.26M1.71M3.11M0.48M0.37M3.16M1.12M2.02M1.12M1.07M
Payables (Quarter) 1.91M2.39M2.20M5.57M0.60M4.26M1.71M3.11M0.48M0.37M3.16M1.12M2.02M1.12M1.07M
Accumulated Expenses (Quarter) 6.16M8.17M4.01M7.97M9.88M14.94M26.69M28.21M14.17M13.01M19.01M22.40M13.10M13.60M18.25M
Total Current Liabilities (Quarter) 8.07M10.56M6.21M13.54M10.48M19.20M28.40M31.32M14.65M13.39M22.17M23.52M15.11M14.72M19.32M
Non-Current Liabilities
Non-Current Debt (Quarter) 97.62M
Preferred Stock Liabilities (Quarter) 40.99M117.66M117.66M117.66M
Total Liabilities (Quarter) 116.94M
Shareholder's Equity
Common Equity (Quarter) 550.92M
Liabilities and Shareholders Equity (Quarter) 667.85M
Total Debt (Quarter) 97.62M
Retained Earnings (Quarter) 1,288.49M
Treasury Shares (Quarter) 136.51M136.51M86.33M1.01M0.37M0.13M